These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 29150490)

  • 1. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.
    Gerbes A; Zoulim F; Tilg H; Dufour JF; Bruix J; Paradis V; Salem R; Peck-Radosavljevic M; Galle PR; Greten TF; Nault JC; Avila MA
    Gut; 2018 Feb; 67(2):380-388. PubMed ID: 29150490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Peng ZW; Chen MS
    Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Hepatocellular carcinoma: A life-threatening disease".
    Chacko S; Samanta S
    Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatocellular carcinoma.
    Del Pozo AC; López P
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.
    Sacco R; Mirabile A; Giacomelli L; Bresci G; Attardo S; Cabibbo G
    Future Oncol; 2017 Jun; 13(15):1297-1300. PubMed ID: 28589772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation.
    Liapi E; Geschwind JF
    Ann Surg Oncol; 2011 Jun; 18(6):1527-8. PubMed ID: 21431403
    [No Abstract]   [Full Text] [Related]  

  • 13. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multimodality treatment for hepatocellular carcinoma].
    Malek NP; Vogel A; Manns MP
    Internist (Berl); 2010 Nov; 51(11):1374-81. PubMed ID: 20938626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
    Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
    Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional oncology for hepatocellular carcinoma.
    Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.